Search Clinical Trials Search
Clinical Trials
× ...
Sort & Filter
Sort by
Specialty

Disease Type/Condition

Age Group


Drug/Medication


22 results found


Other

A 52-Week, Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196)...

Primary Objective: To evaluate the safety and tolerability of once-daily, oral administration of 80 or 100 mg resmetirom versus matching placebo as measured by: Incidence of Adverse Events [ Time Frame: 52 ...


Other

A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and...

This study focuses on individuals with ulcerative colitis (UC) that has been assessed as being moderate to severe. The purpose of the study is to determine whether ...


Liver

ALTUS2021-01: ALTUS: Performance of a Multi-Target Hepatocellular Carcinoma (HCC) Test in Subjects...

Primary Objective: Assess overall sensitivity and specificity of Oncoguard Liver for hepatocellular cancer (HCC) detection in a surveillance population. Secondary Objective(s): Assess performance of Oncoguard Liver in confirmed HCC and non-HCC population. Assess ...


Other

A two-part, randomized, placebo controlled, double blind, multicenter, Phase 3 study to evaluate...

Primary: To investigate the effect of treatment with oral linerixibat compared with placebo on itch in PBC patients with cholestatic pruritus over 24 weeks (Part A) Secondary: - To evaluate the early effects ...


Other

A Prospective, Open-Label, Multi-Center, Randomized, Pivotal Safety and Efficacy Study of the Allurion...

Co-Primary Effectiveness Endpoint 1: Responder Rate (RR) dichotomized at 5% TBWL at 48 weeks is significantly greater than 50%. Co-Primary Effectiveness Endpoint 2: Treatment Group mean %TBWL is significantly greater than Control Group ...